Home / Drug shortages / Morphine Sulfate Injection

Morphine Sulfate Injection — FDA Drug Shortage

Current — Hikma Pharmaceuticals USA, Inc.

The FDA lists a drug shortage record for Morphine Sulfate Injection (injection) from Hikma Pharmaceuticals USA, Inc. with status Current. The shortage was first posted on 11/03/2017.

Shortage Details

Status
Current
Company
Hikma Pharmaceuticals USA, Inc.
Package NDC
0641-6039-01
Dosage Form
Injection
Presentation
Infumorph 200 (Preservative-Free Morphine Sulfate Sterile Solution), Injection, 10 mg/1 mL (NDC 0641-6039-01)
Initial Posting
11/03/2017
Revised Date

FDA data resources